Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

NCT06932263 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Tozorakimab
DRUG: Placebo

Sponsor

AstraZeneca